Financial, market and economic news

3 Green Flags for Aurora Cannabis’ Future

For investors in troubled Canadian marijuana cultivator Aurora Cannabis (NYSE: ACB), good news is in short supply. The company is nowhere near profitability, and its stock has been falling since March of last year, culminating in a massive collapse in September.

In its latest earnings report, Aurora disclosed that its sales revenues were down 5% from the previous quarter, capping a long string of losses. If that weren’t enough, shareholders are mounting a lawsuit against the company, alleging that it misled investors in early 2020 about the stock’s potential.

But there have been a few positive developments to give shareholders and potential investors a glimmer of hope. Support for cannabis legalization is increasing, and Aurora’s own leadership team is changing, all of which could mean a turn in the company’s luck. And while those factors won’t be enough to make the stock worth a purchase in the short term, they’ll definitely contribute to the company’s turnaround effort.

Continue reading

Read More

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. AcceptRead More

Privacy & Cookies Policy